サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：北米の美容皮膚科市場 (～2029年)：産業動向・予測
市場調査レポート
商品コード
1109762

北米の美容皮膚科市場 (～2029年)：産業動向・予測

NA Aesthetic Dermatology Market - Industry Trends and Forecast to 2029
出版日: | 発行: Data Bridge Market Research | ページ情報: 英文 246 Pages | 納期: お問合せ

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
北米の美容皮膚科市場 (～2029年)：産業動向・予測
出版日: 2022年05月01日
発行: Data Bridge Market Research
ページ情報: 英文 246 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の美容皮膚科の市場規模は、は予測期間中に10.3%のCAGRで成長すると予測されています。

美容整形に対する支出の増加、技術的進歩の高まりなどの要因が同市場の成長を推進しています。

当レポートでは、北米の美容皮膚科の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合情勢、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 市場の分類

第3章 エグゼクティブサマリー

第4章 重要考察

  • ポーターズファイブフォース
  • PESTEL分析

第5章 北米の美容皮膚科市場：法規制

第6章 市場概要

  • 促進要因
  • 抑制要因
  • 機会
  • 課題

第7章 北米の美容皮膚科市場：製品タイプ別

  • 概要
  • 薬
    • ボトックス
    • 皮膚フィラー
    • その他
  • デバイス
    • エネルギーベースデバイス
    • 非エネルギーベースデバイス

第8章 北米の美容皮膚科市場：手術タイプ別

  • 概要
  • 低侵襲
  • 非侵襲的

第9章 北米の美容皮膚科市場：治療タイプ別

  • 概要
  • フェイストリートメント
    • 肌の若返り
    • スキンリサーフェイシング
    • 肌の引き締め
    • 脱毛
    • にきび
    • 色素沈着・血管病変
    • タトゥー除去
    • 傷跡
    • 異色症
    • 乾癬
    • スキンタグ
    • いぼ
    • ほくろ・そばかす
    • 多汗症
    • その他
  • ボディトリートメント
    • 肌の若返り
    • スキンリサーフェイシング
    • 肌の引き締め
    • 脱毛
    • 色素沈着・血管病変
    • タトゥー除去
    • 傷跡
    • スキンタグ
    • 多汗症
    • 乾癬
    • 異色症
    • いぼ
    • ほくろとそばかす
    • にきび
    • その他

第10章 北米の美容皮膚科市場：用途別

  • 概要
  • 肌の若返り
  • スキンリサーフェイシング
  • 肌の引き締め
  • 脱毛
  • 色素沈着・血管病変
  • タトゥー除去
  • 傷跡
  • にきび
  • 異色症
  • スキンタグ
  • 乾癬
  • いぼ
  • 多汗症
  • ほくろ・そばかす
  • その他

第11章 北米の美容皮膚科市場：性別

  • 概要
  • 女性
  • 男性

第12章 北米の美容皮膚科市場：エンドユーザー別

  • 概要
  • 病院
  • 皮膚科クリニック
  • 外科センター
  • スパクリニック
  • その他

第13章 北米の美容皮膚科市場：流通経路別

  • 概要
  • 直接販売
  • 小売

第14章 北米の美容皮膚科市場：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ

第15章 北米の美容皮膚科市場：企業情勢

  • 企業シェア分析：北米

第16章 SWOT分析

第17章 企業プロファイル

  • ABBVIE INC.
  • BAUSCH HEALTH COMPANIES INC.
  • HENRY SCHEIN, INC.
  • MERZ PHARMA
  • CANDELA MEDICAL
  • AEROLASE CORP.
  • AESTHETIC TECHNOLOGY LIMITED
  • AESTHETIC BIOMEDICAL
  • ALMA LASERS
  • BIOTECH ITALIA SRL
  • CUTERA
  • CYNOSURE. INC.
  • DELEO
  • EL. EN. S.P.A.
  • EVOLUS, INC.
  • FOTONA
  • HAOHAI BIOLOGICAL TECHNOLOGY
  • HUGEL, INC.
  • IMAGE DERM, INC.
  • LUMENIS BE LTD.
  • LUTRONIC
  • MEDENCY
  • MEDYTOX
  • PHOTOMEDEX
  • R2 TECHNOLOGIES, INC.
  • REVANCE THERAPEUTICS
  • SCITON
  • SENSUS HEALTHCARE, INC.
  • THERMIGEN, LLC.
  • VENUS CONCEPT

第18章 アンケート

第19章 関連レポート

図表

LIST OF TABLES

  • TABLE 1 DEVICES WITH AESTHETIC PURPOSE LISTED IN FDA MEDICAL DEVICE CLASSIFICATION DATABASE 46
  • TABLE 2 GOVERNMENT PROCESSING FEE 50
  • TABLE 3 AMERICAN SOCIETY FOR AESTHETIC PLASTIC SURGERY PROCEDURE FACTS 56
  • TABLE 4 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 64
  • TABLE 5 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS) 65
  • TABLE 6 NORTH AMERICA MEDICINES IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 65
  • TABLE 7 NORTH AMERICA MEDICINES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 66
  • TABLE 8 NORTH AMERICA DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 67
  • TABLE 9 NORTH AMERICA DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 67
  • TABLE 10 NORTH AMERICA ENERGY BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 68
  • TABLE 11 NORTH AMERICA LASER BASED DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 68
  • TABLE 12 NORTH AMERICA NON-ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 69
  • TABLE 13 NORTH AMERICA ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 70
  • TABLE 14 NORTH AMERICA NON-ENERGY BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 71
  • TABLE 15 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 75
  • TABLE 16 NORTH AMERICA MINIMALLY INVASIVE IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 76
  • TABLE 17 NORTH AMERICA NON-INVASIVE IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 77
  • TABLE 18 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 81
  • TABLE 19 NORTH AMERICA FACE TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 82
  • TABLE 20 NORTH AMERICA FACE TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 83
  • TABLE 21 NORTH AMERICA BODY TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 85
  • TABLE 22 NORTH AMERICA BODY TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 86
  • TABLE 23 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 93
  • TABLE 24 NORTH AMERICA SKIN REJUVENATION IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 94
  • TABLE 25 NORTH AMERICA SKIN RESURFACING IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 95
  • TABLE 26 NORTH AMERICA SKIN TIGHTENING IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 96
  • TABLE 27 NORTH AMERICA HAIR REMOVAL IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 97
  • TABLE 28 NORTH AMERICA PIGMENTED & VASCULAR LESION IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 97
  • TABLE 29 NORTH AMERICA TATTOO REMOVAL IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 98
  • TABLE 30 NORTH AMERICA SCAR IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 99
  • TABLE 31 NORTH AMERICA ACNE IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 100
  • TABLE 32 NORTH AMERICA DYSCHROMIA IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 101
  • TABLE 33 NORTH AMERICA SKIN TAGS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 101
  • TABLE 34 NORTH AMERICA PSORIASIS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 102
  • TABLE 35 NORTH AMERICA WARTS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 103
  • TABLE 36 NORTH AMERICA HYPERHIDROSIS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 104
  • TABLE 37 NORTH AMERICA MOLES & FRECKLES IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 104
  • TABLE 38 NORTH AMERICA OTHERS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 105
  • TABLE 39 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY GENDER, 2020-2029 (USD MILLION) 109
  • TABLE 40 NORTH AMERICA FEMALE IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 110
  • TABLE 41 NORTH AMERICA MALE IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 111
  • TABLE 42 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY END USER, 2020-2029 (USD MILLION) 115
  • TABLE 43 NORTH AMERICA HOSPITALS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 116
  • TABLE 44 NORTH AMERICA DERMATOLOGY CLINICS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 117
  • TABLE 45 NORTH AMERICA SURGICAL CENTERS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 118
  • TABLE 46 NORTH AMERICA SPA CLINICS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 118
  • TABLE 47 NORTH AMERICA OTHERS IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 119
  • TABLE 48 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 123
  • TABLE 49 NORTH AMERICA DIRECT TENDER IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 124
  • TABLE 50 NORTH AMERICA RETAIL SALES IN AESTHETIC DERMATOLOGY MARKET, BY REGION, 2020-2029 (USD MILLION) 125
  • TABLE 51 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 132
  • TABLE 52 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 53 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS) 132
  • TABLE 54 NORTH AMERICA MEDICINES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 55 NORTH AMERICA DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 133
  • TABLE 56 NORTH AMERICA ENERGY BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 133
  • TABLE 57 NORTH AMERICA LASER BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 133
  • TABLE 58 NORTH AMERICA NON-ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 133
  • TABLE 59 NORTH AMERICA ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 134
  • TABLE 60 NORTH AMERICA NON-ENERGY BASED DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 134
  • TABLE 61 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 134
  • TABLE 62 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 134
  • TABLE 63 NORTH AMERICA FACE TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 135
  • TABLE 64 NORTH AMERICA BODY TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 136
  • TABLE 65 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 137
  • TABLE 66 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY GENDER, 2020-2029 (USD MILLION) 137
  • TABLE 67 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY END USER, 2020-2029 (USD MILLION) 138
  • TABLE 68 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 138
  • TABLE 69 U.S. AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 139
  • TABLE 70 U.S. AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS) 139
  • TABLE 71 U.S. MEDICINES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 139
  • TABLE 72 U.S. DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 139
  • TABLE 73 U.S. ENERGY BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 140
  • TABLE 74 U.S. LASER BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 140
  • TABLE 75 U.S. NON-ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 140
  • TABLE 76 U.S. ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 140
  • TABLE 77 U.S. NON-ENERGY BASED DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 141
  • TABLE 78 U.S. AESTHETIC DERMATOLOGY MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 141
  • TABLE 79 U.S. AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 141
  • TABLE 80 U.S. FACE TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 142
  • TABLE 81 U.S. BODY TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 143
  • TABLE 82 U.S. AESTHETIC DERMATOLOGY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 144
  • TABLE 83 U.S. AESTHETIC DERMATOLOGY MARKET, BY GENDER, 2020-2029 (USD MILLION) 144
  • TABLE 84 U.S. AESTHETIC DERMATOLOGY MARKET, BY END USER, 2020-2029 (USD MILLION) 144
  • TABLE 85 U.S. AESTHETIC DERMATOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 145
  • TABLE 86 CANADA AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 146
  • TABLE 87 CANADA AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS) 146
  • TABLE 88 CANADA MEDICINES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 146
  • TABLE 89 CANADA DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 146
  • TABLE 90 CANADA ENERGY BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 147
  • TABLE 91 CANADA LASER BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 147
  • TABLE 92 CANADA NON-ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 147
  • TABLE 93 CANADA ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 147
  • TABLE 94 CANADA NON-ENERGY BASED DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 148
  • TABLE 95 CANADA AESTHETIC DERMATOLOGY MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 148
  • TABLE 96 CANADA AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 148
  • TABLE 97 CANADA FACE TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 149
  • TABLE 98 CANADA BODY TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 150
  • TABLE 99 CANADA AESTHETIC DERMATOLOGY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 151
  • TABLE 100 CANADA AESTHETIC DERMATOLOGY MARKET, BY GENDER, 2020-2029 (USD MILLION) 151
  • TABLE 101 CANADA AESTHETIC DERMATOLOGY MARKET, BY END USER, 2020-2029 (USD MILLION) 151
  • TABLE 102 CANADA AESTHETIC DERMATOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 152
  • TABLE 103 MEXICO AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 153
  • TABLE 104 MEXICO AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS) 153
  • TABLE 105 MEXICO MEDICINES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 153
  • TABLE 106 MEXICO DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 153
  • TABLE 107 MEXICO ENERGY BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 154
  • TABLE 108 MEXICO LASER BASED DEVICE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 154
  • TABLE 109 MEXICO NON-ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 154
  • TABLE 110 MEXICO ABLATIVE IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 154
  • TABLE 111 MEXICO NON-ENERGY BASED DEVICES IN AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 155
  • TABLE 112 MEXICO AESTHETIC DERMATOLOGY MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION) 155
  • TABLE 113 MEXICO AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 155
  • TABLE 114 MEXICO FACE TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 156
  • TABLE 115 MEXICO BODY TREATMENT IN AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE, 2020-2029 (USD MILLION) 157
  • TABLE 116 MEXICO AESTHETIC DERMATOLOGY MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 158
  • TABLE 117 MEXICO AESTHETIC DERMATOLOGY MARKET, BY GENDER, 2020-2029 (USD MILLION) 158
  • TABLE 118 MEXICO AESTHETIC DERMATOLOGY MARKET, BY END USER, 2020-2029 (USD MILLION) 158
  • TABLE 119 MEXICO AESTHETIC DERMATOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 159

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: SEGMENTATION 25
  • FIGURE 2 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: DATA TRIANGULATION 28
  • FIGURE 3 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: DROC ANALYSIS 29
  • FIGURE 4 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 30
  • FIGURE 5 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: COMPANY RESEARCH ANALYSIS 30
  • FIGURE 6 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: INTERVIEW DEMOGRAPHICS 32
  • FIGURE 7 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: DBMR MARKET POSITION GRID 33
  • FIGURE 8 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: END USER COVERAGE GRID 34
  • FIGURE 9 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: VENDOR SHARE ANALYSIS 35
  • FIGURE 10 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: SEGMENTATION 39
  • FIGURE 11 GROWING DESIRE TO IMPROVE ONE'S APPEARANCE AND RISE IN PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES ARE EXPECTED TO DRIVE THE NORTH AMERICA AESTHETIC DERMATOLOGY MARKET FROM 2021 TO 2029 40
  • FIGURE 12 MEDICINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA AESTHETIC DERMATOLOGY MARKET IN 2022 & 2029 40
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD 41
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA AESTHETIC DERMATOLOGY MARKET 51
  • FIGURE 15 NUMBER OF AESTHETIC PROCEDURES PERFORMED, U.S., 2020 52
  • FIGURE 16 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY PRODUCT TYPE, 2021 61
  • FIGURE 17 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION) 62
  • FIGURE 18 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY PRODUCT TYPE, CAGR (2022-2029) 62
  • FIGURE 19 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY PRODUCT TYPE, LIFELINE CURVE 63
  • FIGURE 20 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY SURGERY TYPE, 2021 72
  • FIGURE 21 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY SURGERY TYPE, 2022-2029 (USD MILLION) 73
  • FIGURE 22 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY SURGERY TYPE, CAGR (2022-2029) 73
  • FIGURE 23 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY SURGERY TYPE, LIFELINE CURVE 74
  • FIGURE 24 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY TREATMENT TYPE, 2021 78
  • FIGURE 25 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY TREATMENT TYPE, 2022-2029 (USD MILLION) 79
  • FIGURE 26 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY TREATMENT TYPE, CAGR (2022-2029) 79
  • FIGURE 27 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY TREATMENT TYPE, LIFELINE CURVE 80
  • FIGURE 28 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY APPLICATION, 2021 89
  • FIGURE 29 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY APPLICATION, 2022-2029 (USD MILLION) 90
  • FIGURE 30 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY APPLICATION, CAGR (2022-2029) 90
  • FIGURE 31 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY APPLICATION, LIFELINE CURVE 91
  • FIGURE 32 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY GENDER, 2021 106
  • FIGURE 33 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY GENDER, 2022-2029 (USD MILLION) 107
  • FIGURE 34 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY GENDER, CAGR (2022-2029) 107
  • FIGURE 35 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY GENDER, LIFELINE CURVE 108
  • FIGURE 36 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY END USER, 2021 112
  • FIGURE 37 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY END USER, 2022-2029 (USD MILLION) 113
  • FIGURE 38 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY END USER, CAGR (2022-2029) 113
  • FIGURE 39 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY END USER, LIFELINE CURVE 114
  • FIGURE 40 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2021 120
  • FIGURE 41 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 121
  • FIGURE 42 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 121
  • FIGURE 43 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 122
  • FIGURE 44 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: SNAPSHOT (2021) 127
  • FIGURE 45 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY COUNTRY (2021) 129
  • FIGURE 46 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY COUNTRY (2022 & 2029) 129
  • FIGURE 47 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY COUNTRY (2021 & 2029) 130
  • FIGURE 48 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: BY PRODUCT TYPE (2022-2029) 130
  • FIGURE 49 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: COMPANY SHARE 2021 (%) 159
目次

The North America aesthetic dermatology market is projected to register a substantial CAGR of 10.3% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2020, and the forecast period is 2022 to 2029.

Market Segmentation:

North America Dermatology Market, By Product Type (Medicines and Devices), Surgery Type (Minimally Invasive and Non-Invasive), Treatment Type (Face Treatment and Body Treatment), Application (Skin Rejuvenation, Skin Resurfacing, Skin Tightening, Hair Removal, Pigmented & Vascular Lesions, Tattoo Removal, Scar, Acne, Dyschromia, Skin Tags, Psoriasis, Warts, Hyperhidrosis, Moles and Freckles and Others), Gender (Female and Male), End User (Hospitals, Dermatology Clinics, Surgical Centers, Spa Clinics and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico) - Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of North America aesthetic dermatology market are:

  • Increasing spending on aesthetic procedures
  • Growing technological advancements

Market Players:

The major companies which are dealing in the North America aesthetic dermatology market are listed below:

  • AbbVie Inc.
  • Henry Schein, Inc.
  • Merz Pharma, Cutera
  • Cynosure. Inc. (A Subsidiary of Hologic, Inc.)
  • Candela Medical, Bausch Health Companies Inc.
  • Evolus, Inc.
  • Medytox
  • LUTRONIC
  • HUGEL, Inc.
  • El. En. S.p.A.
  • Hoahai
  • REVANCE THERAPEUTICS
  • Lumenis Be Ltd.
  • Venus Concept
  • Alma Lasers
  • Fotona
  • Aesthetic Biomedical
  • ThermiGen, LLC.
  • R2 TECHNOLOGIES, INC. (A Subsidiary of INNOVATE Corp.)
  • Sensus Healthcare, Inc.
  • Aesthetic Technology Limited
  • DELEO
  • Aerolase Corp.
  • Sciton
  • Image Derm, Inc.
  • PhotoMedex

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF THE NORTH AMERICA AESTHETIC DERMATOLOGY MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCT TYPE LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET END USER COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PORTERS FIVE FORCES
  • 4.2 PESTEL ANALYSIS

5 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: REGULATIONS

  • 5.1 U.S.
  • 5.2 EUROPEAN UNION
  • 5.3 CHINA
  • 5.4 THAILAND
  • 5.5 BRAZIL

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 GROWING DESIRE TO IMPROVE ONE'S APPEARANCE
    • 6.1.2 RISE IN PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
    • 6.1.3 ADVANCEMENT IN HEALTHCARE TECHNOLOGY & INFRASTRUCTURE
    • 6.1.4 INCREASE IN AESTHETIC EXPENDITURE
  • 6.2 RESTRAINTS
    • 6.2.1 HIGH COST OF AESTHETIC SURGICAL PROCEDURES
    • 6.2.2 SIDE EFFECTS RELATED TO AESTHETIC TREATMENTS
  • 6.3 OPPORTUNITIES
    • 6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
    • 6.3.2 INCREASE IN RESEARCH AND DEVELOPMENT
    • 6.3.3 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES
    • 6.3.4 GROW IN AWARENESS OF AESTHETIC PROCEDURES
  • 6.4 CHALLENGES
    • 6.4.1 LACK OF SKILLED PROFESSIONALS
    • 6.4.2 LONG APPROVAL TIME ASSOCIATED WITH PRODUCT LAUNCH

7 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY PRODUCT TYPE

  • 7.1 OVERVIEW
  • 7.2 MEDICINES
    • 7.2.1 BOTOX
    • 7.2.2 DERMAL FILLERS
    • 7.2.3 OTHERS
  • 7.3 DEVICES
    • 7.3.1 ENERGY BASED DEVICE
      • 7.3.1.1 LASER BASED DEVICE
        • 7.3.1.1.1 NON-ABLATIVE
        • 7.3.1.1.1.1 PULSE ENERGY LASER
        • 7.3.1.1.1.2 ND:YAG
        • 7.3.1.1.1.3 DIODE LASER
        • 7.3.1.1.1.4 OTHERS
        • 7.3.1.1.2 ABLATIVE
        • 7.3.1.1.2.1 CARBON DIOXIDE LASER
        • 7.3.1.1.2.2 ER:YAG LASER
        • 7.3.1.1.2.3 COMBINED CO2 ER:YAG LASER
      • 7.3.1.2 RADIOFREQUENCY (RF) BASED DEVICE
      • 7.3.1.3 LIGHT BASED DEVICE
      • 7.3.1.4 ULTRASOUND BASED DEVICE
      • 7.3.1.5 OTHERS
    • 7.3.2 NON-ENERGY BASED DEVICE
      • 7.3.2.1 MICRODERMABRASION DEVICES
      • 7.3.2.2 THREADS
      • 7.3.2.3 CRYOTHERAPY DEVICES
      • 7.3.2.4 OTHERS

8 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY SURGERY TYPE

  • 8.1 OVERVIEW
  • 8.2 MINIMALLY INVASIVE
  • 8.3 NON-INVASIVE

9 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY TREATMENT TYPE

  • 9.1 OVERVIEW
  • 9.2 FACE TREATMENT
    • 9.2.1 SKIN REJUVENATION
    • 9.2.2 SKIN RESURFACING
    • 9.2.3 SKIN TIGHTENING
    • 9.2.4 HAIR REMOVAL
    • 9.2.5 ACNE
    • 9.2.6 PIGMENTED & VASCULAR LESIONS
    • 9.2.7 TATTOO REMOVAL
    • 9.2.8 SCAR
    • 9.2.9 DYSCHROMIA
    • 9.2.10 PSORIASIS
    • 9.2.11 SKIN TAGS
    • 9.2.12 WARTS
    • 9.2.13 MOLES & FRECKLES
    • 9.2.14 HYPERHIDROSIS
    • 9.2.15 OTHERS
  • 9.3 BODY TREATMENT
    • 9.3.1 SKIN REJUVENATION
    • 9.3.2 SKIN RESURFACING
    • 9.3.3 SKIN TIGHTENING
    • 9.3.4 HAIR REMOVAL
    • 9.3.5 PIGMENTED & VASCULAR LESIONS
    • 9.3.6 TATTOO REMOVAL
    • 9.3.7 SCAR
    • 9.3.8 SKIN TAGS
    • 9.3.9 HYPERHIDROSIS
    • 9.3.10 PSORIASIS
    • 9.3.11 DYSCHROMIA
    • 9.3.12 WARTS
    • 9.3.13 MOLES & FRECKLES
    • 9.3.14 ACNE
    • 9.3.15 OTHERS

10 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY APPLICATION

  • 10.1 OVERVIEW
  • 10.2 SKIN REJUVENATION
  • 10.3 SKIN RESURFACING
  • 10.4 SKIN TIGHTENING
  • 10.5 HAIR REMOVAL
  • 10.6 PIGMENTED & VASCULAR LESIONS
  • 10.7 TATTOO REMOVAL
  • 10.8 SCAR
  • 10.9 ACNE
  • 10.10 DYSCHROMIA
  • 10.11 SKIN TAGS
  • 10.12 PSORIASIS
  • 10.13 WARTS
  • 10.14 HYPERHIDROSIS
  • 10.15 MOLES & FRECKLES
  • 10.16 OTHERS

11 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY GENDER

  • 11.1 OVERVIEW
  • 11.2 FEMALE
  • 11.3 MALE

12 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY END USER

  • 12.1 OVERVIEW
  • 12.2 HOSPITALS
  • 12.3 DERMATOLOGY CLINICS
  • 12.4 SURGICAL CENTERS
  • 12.5 SPA CLINICS
  • 12.6 OTHERS

13 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY DISTRIBUTION CHANNEL

  • 13.1 OVERVIEW
  • 13.2 DIRECT TENDER
  • 13.3 RETAIL SALES

14 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET, BY REGION

  • 14.1 NORTH AMERICA
    • 14.1.1 U.S.
    • 14.1.2 CANADA
    • 14.1.3 MEXICO

15 NORTH AMERICA AESTHETIC DERMATOLOGY MARKET: COMPANY LANDSCAPE

  • 15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

16 SWOT ANALYSIS

17 COMPANY PROFILE

  • 17.1 ABBVIE INC.
    • 17.1.1 COMPANY SNAPSHOT
    • 17.1.2 RECENT FINANCIALS
    • 17.1.3 COMPANY SHARE ANALYSIS
    • 17.1.4 PRODUCT PORTFOLIO
    • 17.1.5 RECENT DEVELOPMENTS
  • 17.2 BAUSCH HEALTH COMPANIES INC.
    • 17.2.1 COMPANY SNAPSHOT
    • 17.2.2 RECENT FINANCIALS
    • 17.2.3 COMPANY SHARE ANALYSIS
    • 17.2.4 PRODUCT PORTFOLIO
    • 17.2.5 RECENT DEVELOPMENT
  • 17.3 HENRY SCHEIN, INC.
    • 17.3.1 COMPANY SNAPSHOT
    • 17.3.2 RECENT FINANCIALS
    • 17.3.3 COMPANY SHARE ANALYSIS
    • 17.3.4 PRODUCT PORTFOLIO
    • 17.3.5 RECENT DEVELOPMENTS
  • 17.4 MERZ PHARMA
    • 17.4.1 COMPANY SNAPSHOT
    • 17.4.2 COMPANY SHARE ANALYSIS
    • 17.4.3 PRODUCT PORTFOLIO
    • 17.4.4 RECENT DEVELOPMENTS
  • 17.5 CANDELA MEDICAL
    • 17.5.1 COMPANY SNAPSHOT
    • 17.5.2 COMPANY SHARE ANALYSIS
    • 17.5.3 PRODUCT PORTFOLIO
    • 17.5.4 RECENT DEVELOPMENT
  • 17.6 AEROLASE CORP.
    • 17.6.1 COMPANY SNAPSHOT
    • 17.6.2 PRODUCT PORTFOLIO
    • 17.6.3 RECENT DEVELOPMENTS
  • 17.7 AESTHETIC TECHNOLOGY LIMITED
    • 17.7.1 COMPANY SNAPSHOT
    • 17.7.2 PRODUCT PORTFOLIO
    • 17.7.3 RECENT DEVELOPMENTS
  • 17.8 AESTHETIC BIOMEDICAL
    • 17.8.1 COMPANY SNAPSHOT
    • 17.8.2 PRODUCT PORTFOLIO
    • 17.8.3 RECENT DEVELOPMENTS
  • 17.9 ALMA LASERS
    • 17.9.1 COMPANY SNAPSHOT
    • 17.9.2 PRODUCT PORTFOLIO
    • 17.9.3 RECENT DEVELOPMENTS
  • 17.10 BIOTECH ITALIA SRL
    • 17.10.1 COMPANY SNAPSHOT
    • 17.10.2 PRODUCT PORTFOLIO
    • 17.10.3 RECENT DEVELOPMENTS
  • 17.11 CUTERA
    • 17.11.1 COMPANY SNAPSHOT
    • 17.11.2 RECENT FINANCIALS
    • 17.11.3 PRODUCT PORTFOLIO
    • 17.11.4 RECENT DEVELOPMENTS
  • 17.12 CYNOSURE. INC. (A SUBSIDIARY OF HOLOGIC, INC.)
    • 17.12.1 COMPANY SNAPSHOT
    • 17.12.2 PRODUCT PORTFOLIO
    • 17.12.3 RECENT DEVELOPMENT
  • 17.13 DELEO
    • 17.13.1 COMPANY SNAPSHOT
    • 17.13.2 PRODUCT PORTFOLIO
    • 17.13.3 RECENT DEVELOPMENTS
  • 17.14 EL. EN. S.P.A.
    • 17.14.1 COMPANY SNAPSHOT
    • 17.14.2 RECENT FINANCIALS
    • 17.14.3 PRODUCT PORTFOLIO
    • 17.14.4 RECENT DEVELOPMENTS
  • 17.15 EVOLUS, INC.
    • 17.15.1 COMPANY SNAPSHOT
    • 17.15.2 RECENT FINANCIALS
    • 17.15.3 PRODUCT PORTFOLIO
    • 17.15.4 RECENT DEVELOPMENT
  • 17.16 FOTONA
    • 17.16.1 COMPANY SNAPSHOT
    • 17.16.2 PRODUCT PORTFOLIO
    • 17.16.3 RECENT DEVELOPMENT
  • 17.17 HAOHAI BIOLOGICAL TECHNOLOGY
    • 17.17.1 COMPANY SNAPSHOT
    • 17.17.2 RECENT FINANCIALS
    • 17.17.3 PRODUCT PORTFOLIO
    • 17.17.4 RECENT DEVELOPMENTS
  • 17.18 HUGEL, INC.
    • 17.18.1 COMPANY SNAPSHOT
    • 17.18.2 RECENT FINANCIALS
    • 17.18.3 PRODUCT PORTFOLIO
    • 17.18.4 RECENT DEVELOPMENT
  • 17.19 IMAGE DERM, INC.
    • 17.19.1 COMPANY SNAPSHOT
    • 17.19.2 PRODUCT PORTFOLIO
    • 17.19.3 RECENT DEVELOPMENTS
  • 17.20 LUMENIS BE LTD.
    • 17.20.1 COMPANY SNAPSHOT
    • 17.20.2 PRODUCT PORTFOLIO
    • 17.20.3 RECENT DEVELOPMENT
  • 17.21 LUTRONIC
    • 17.21.1 COMPANY SNAPSHOT
    • 17.21.2 RECENT FINANCIALS
    • 17.21.3 PRODUCT PORTFOLIO
    • 17.21.4 RECENT DEVELOPMENT
  • 17.22 MEDENCY
    • 17.22.1 COMPANY SNAPSHOT
    • 17.22.2 PRODUCT PORTFOLIO
    • 17.22.3 RECENT DEVELOPMENTS
  • 17.23 MEDYTOX
    • 17.23.1 COMPANY SNAPSHOT
    • 17.23.2 RECENT FINANCIALS
    • 17.23.3 PRODUCT PORTFOLIO
    • 17.23.4 RECENT DEVELOPMENT
  • 17.24 PHOTOMEDEX
    • 17.24.1 COMPANY SNAPSHOT
    • 17.24.2 PRODUCT PORTFOLIO
    • 17.24.3 RECENT DEVELOPMENTS
  • 17.25 R2 TECHNOLOGIES, INC. (A SUBSIDIARY OF INNOVATE CORP.)
    • 17.25.1 COMPANY SNAPSHOT
    • 17.25.2 PRODUCT PORTFOLIO
    • 17.25.3 RECENT DEVELOPMENTS
  • 17.26 REVANCE THERAPEUTICS
    • 17.26.1 COMPANY SNAPSHOT
    • 17.26.2 RECENT FINANCIALS
    • 17.26.3 PRODUCT PORTFOLIO
    • 17.26.4 RECENT DEVELOPMENTS
  • 17.27 SCITON
    • 17.27.1 COMPANY SNAPSHOT
    • 17.27.2 PRODUCT PORTFOLIO
    • 17.27.3 RECENT DEVELOPMENTS
  • 17.28 SENSUS HEALTHCARE, INC.
    • 17.28.1 COMPANY SNAPSHOT
    • 17.28.2 PRODUCT PORTFOLIO
    • 17.28.3 RECENT DEVELOPMENT
  • 17.29 THERMIGEN, LLC.
    • 17.29.1 COMPANY SNAPSHOT
    • 17.29.2 PRODUCT PORTFOLIO
    • 17.29.3 RECENT DEVELOPMENTS
  • 17.30 VENUS CONCEPT
    • 17.30.1 COMPANY SNAPSHOT
    • 17.30.2 RECENT FINANCIALS
    • 17.30.3 PRODUCT PORTFOLIO
    • 17.30.4 RECENT DEVELOPMENTS

18 QUESTIONNAIRE

19 RELATED REPORTS